pcDNA3.1 SARS-CoV-2 N Citations (3)
Originally described in: Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro JB, Rafique A, Barve A, Sabeti PC, Kyratsous CA, Dudkina NV, Shen K, Luban J Cell. 2020 Sep 15. pii: S0092-8674(20)31229-0. doi: 10.1016/j.cell.2020.09.032. PubMed Journal
Articles Citing pcDNA3.1 SARS-CoV-2 N
Articles |
---|
Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection. Ariumi Y. J Virol. 2022 Mar 23;96(6):e0000222. doi: 10.1128/jvi.00002-22. Epub 2022 Feb 2. PubMed |
SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. Yamamoto Y, Inoue T, Inoue M, Murae M, Fukasawa M, Kaneko MK, Kato Y, Noguchi K. Int J Mol Sci. 2022 Dec 13;23(24):15834. doi: 10.3390/ijms232415834. PubMed |
The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins. Bains A, Fischer K, Guan W, LiWang PJ. Viruses. 2023 Dec 18;15(12):2452. doi: 10.3390/v15122452. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.